Researchers develop experimental mRNA avian flu vaccine
An experimental mRNA vaccine against avian influenza virus H5N1 is highly effective in preventing severe illness and death in preclinical models. The vaccine could potentially help manage the outbreak of the H5N1 virus currently ...
22 hours ago
0
12
Factors potentially contributing to the decline of the mpox outbreak in the Netherlands, 2022 and 2023
Research by experts from The Dutch National Institute for Public Health and the Environment (RIVM) hypothesize that it is not likely that preventive vaccination was a driver of the outbreak's decline, as the mpox incidence ...
18 hours ago
0
0
Study shows shingles vaccine uptake increased after Inflation Reduction Act removed patient out-of-pocket cost
Among the aims of the Inflation Reduction Act (IRA) is reducing health care costs for older adults by eliminating cost sharing for certain drugs and vaccines covered by Medicare Part D. To help determine whether the impact ...
20 hours ago
0
1
Myths incorrectly connecting COVID vaccine to heart defects may be spreading
The American Heart Association warns that false information about COVID vaccination and heart defects attributed to the Association may be spreading. The misinformation is inaccurately and incorrectly connected to a recent ...
17 hours ago
0
1
Century-old vaccine found to protect type 1 diabetics from infectious diseases
In new research, investigators at Massachusetts General Hospital (MGH) show that the 100-year-old Bacillus Calmette-Guérin (BCG) vaccine, originally developed to prevent tuberculosis, protects individuals with type 1 diabetes ...
May 22, 2024
0
57
Cracking the genetic code for COVID-19 vaccine effectiveness
Researchers have unveiled critical insights into how our genetic makeup influences the body's response to COVID-19 vaccines. The study, published in Nature Communications, may open new paths to personalized vaccination strategies.
May 22, 2024
0
43
To hunt for better malaria vaccines, researchers turn to machine learning
Anti-malaria drugs have been a central component of a global public health effort that saw a 44% drop in the deadly mosquito-borne disease from 2000 to 2019, but progress has stalled as the parasites that cause malaria gain ...
May 22, 2024
0
6
Researchers determine mechanism of action of delta inulin, uncover key to more effective vaccines
Researchers from the Centenary Institute and the University of Sydney have made a major discovery in vaccine science, gaining new insights into delta inulin as a crucial vaccine component. Their findings offer a promising ...
May 22, 2024
0
1
A boost for HIV vaccine research: Studies present comprehensive platform for validating next steps
HIV has proven a hard target for vaccine design. The most promising approach, germline-targeting (GT), proposes a series of immunizations: a first shot to activate inexperienced B cells—antibody-producing white blood cells—followed ...
May 21, 2024
0
17
New tool may help prioritize high-risk infants for RSV immunization
On the heels of a shortage of nirsevimab for infant respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) prevention, a new tool may help identify newborns at highest risk for developing serious RSV LRTI, ...
May 21, 2024
0
0
How a simulation is informing COVID-19 vaccine policy after our 'return to normal'
As the saying goes "There is no such thing as normal" and this has been especially true after the pandemic.
May 20, 2024
0
13
Uptake of flu, whooping cough, and COVID-19 vaccines remains low among pregnant women
A study conducted by researchers at the University of Warwick has unveiled crucial insights into the complex factors shaping vaccination decisions among pregnant women, particularly in the wake of the COVID-19 pandemic.
May 20, 2024
0
12
Repeat COVID-19 vaccinations elicit antibodies that neutralize variants, other viruses
The COVID-19 pandemic is over, but the virus that caused it is still here, sending thousands of people to the hospital each week and spinning off new variants with depressing regularity. The virus's exceptional ability to ...
May 18, 2024
2
145
Trial HIV vaccine triggers elusive and essential antibodies, pointing the way toward a successful vaccine
An HIV vaccine candidate developed at the Duke Human Vaccine Institute triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.
May 17, 2024
0
63
Despite its 'nothingburger' reputation, COVID-19 remains deadlier than the flu
Since the earliest days of the pandemic, health officials have gauged the threat of COVID-19 by comparing it to the flu.
May 16, 2024
0
50
Link between COVID-19 vaccine complication and rare 'common cold' blood disease
New research led by Flinders University and international experts is expanding understanding of vaccine-induced immune thrombocytopenia and thrombosis (known as VITT).
May 16, 2024
0
1
Quality improvement initiative boosts early HPV vaccine rates
A multipronged primary care quality improvement initiative increases early human papillomavirus (HPV) vaccine initiation across racial/ethnic, sociodemographic, insurance, and geographic groups, according to a study presented ...
May 16, 2024
0
14
New study shows continued high effectiveness of HPV vaccination in England
The human papillomavirus (HPV) vaccination program in England has not only been associated with a substantial reduction in cervical disease, but has done so in all socioeconomic groups, finds a study published by The BMJ.
May 15, 2024
0
21